Previous studies suggested that FTO gene polymorphisms were commonly correlated with metabolic disorders, especially central obesity, low-density lipoprotein (LDL), insulin resistance, and hypertriglyceridemia [24], which are tightly related to NAFLD [25]. This evidence concerns the gene FTO and metabolic disease.